+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

From
From
3D Microfluidic Cell Culture - Global Strategic Business Report - Product Thumbnail Image

3D Microfluidic Cell Culture - Global Strategic Business Report

  • Report
  • November 2026
  • 396 Pages
  • Global
From
Escherichia Coli Strain - Global Strategic Business Report - Product Thumbnail Image

Escherichia Coli Strain - Global Strategic Business Report

  • Report
  • November 2026
  • 497 Pages
  • Global
From
Microchip Electrophoresis - Global Strategic Business Report - Product Thumbnail Image

Microchip Electrophoresis - Global Strategic Business Report

  • Report
  • November 2026
  • 188 Pages
  • Global
From
Cell and Tissue Preservation - Global Strategic Business Report - Product Thumbnail Image

Cell and Tissue Preservation - Global Strategic Business Report

  • Report
  • November 2026
  • 596 Pages
  • Global
From
From
Diagnostic Exosome Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Diagnostic Exosome Biomarkers - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
CRISPR Genomic Cure - Global Strategic Business Report - Product Thumbnail Image

CRISPR Genomic Cure - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
High End Cellomics - Global Strategic Business Report 2026 - Product Thumbnail Image

High End Cellomics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 212 Pages
  • Global
From
Biobanking Equipment - Global Strategic Business Report - Product Thumbnail Image

Biobanking Equipment - Global Strategic Business Report

  • Report
  • November 2026
  • 376 Pages
  • Global
From
Omics Lab Services - Global Strategic Business Report - Product Thumbnail Image

Omics Lab Services - Global Strategic Business Report

  • Report
  • November 2026
  • 594 Pages
  • Global
From
From
From
Whole Genome Sequencing - Global Strategic Business Report - Product Thumbnail Image

Whole Genome Sequencing - Global Strategic Business Report

  • Report
  • November 2026
  • 464 Pages
  • Global
From
From
Long Read Sequencing - Global Strategic Business Report - Product Thumbnail Image

Long Read Sequencing - Global Strategic Business Report

  • Report
  • November 2026
  • 579 Pages
  • Global
From
Gene Editing - Global Strategic Business Report - Product Thumbnail Image

Gene Editing - Global Strategic Business Report

  • Report
  • November 2026
  • 383 Pages
  • Global
From
Sequencing Consumables - Global Strategic Business Report - Product Thumbnail Image

Sequencing Consumables - Global Strategic Business Report

  • Report
  • November 2026
  • 381 Pages
  • Global
From
DNA Repair Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

DNA Repair Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 217 Pages
  • Global
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more